-
Vaccines company Novavax Inc. (NASDAQ:NVAX) raised $12.2 million through the sale of 10 million shares at $1.22 in a private placement to RA Capital Healthcare Fund. The price is a 5% premium to Novavax's close of $1.16…
Published on 5/21/2012
-
Kleiner Perkins Caufield & Byers closed its $525 million KPCB XV fund. The fund will invest in early stage digital consumer and enterprise, green tech and life sciences companies.
Published on 5/18/2012
-
Cancer company Tvax Biomedical Inc. (Lenexa, Kan.) withdrew its planned IPO, citing market conditions. The company had planned to sell 2 million shares at $9-$11 per share. A $10 price would have raised $20 million and …
Published on 5/18/2012
-
Kythera Biopharmaceuticals Inc. (Calabasas, Calif.) proposed to raise $86.3 million in an IPO underwritten by JPMorgan; Goldman Sachs; Leerink; and Lazard. Kythera's ATX-101 is in Phase III testing to reduce submental (…
Published on 5/17/2012
-
Ra Pharmaceuticals Inc. (Cambridge, Mass.) raised $8.6 million in the second tranche of a planned $27 million series A round. Ra raised $10.3 million in the first tranche in February 2010. New Enterprise Associates led …
Published on 5/16/2012
-
Arena Pharmaceuticals Inc. (NASDAQ:ARNA) said late Tuesday it is planning a follow-on underwritten by Jefferies; Piper Jaffray; and BMO Capital Markets. On Thursday, an FDA advisory committee voted 18-4, with one …
Published on 5/15/2012
-
Cytos Biotechnology AG (SIX:CYTN) raised CHF30.4 million ($32.6 million) in an equity and debt financing led by venBio, with participation from Amgen Inc. (NASDAQ:AMGN); Abingworth; and Aisling Capital. The financing …
Published on 5/15/2012
-
Newron Pharmaceuticals S.p.A. (SIX:NWRN) jumped CHF1.50 (37%) to CHF5.51 on Tuesday after Zambon Co. S.p.A. (Bresso, Italy) exercised its option to license exclusive rights to develop and commercialize Parkinson's …
Published on 5/15/2012
-
Medicis Pharmaceutical Corp. (NYSE:MRX) raised $450 million in a bumped-up offering of senior convertible notes. The notes bear 1.375% interest and mature on June 1, 2017. They initially covert at $47.07, which is a 22%…
Published on 5/14/2012
-
OncoMed Pharmaceuticals Inc. (Redwood City, Calif.) proposed to raise $115 million in an IPO underwritten by Jefferies; Leerink; Piper Jaffray; and BMO Capital Markets. OncoMed's clinical pipeline includes: demcizumab (…
Published on 5/11/2012
-
Prolor Biotech Inc. (NYSE-A:PBTH; Tel Aviv:PBTH) raised $32.5 million through the sale of 6.5 million shares at $5 in a follow-on underwritten by Jefferies; Ladenburg Thalmann; and Oppenheimer. The company proposed the …
Published on 5/11/2012
-
New Enterprise Associates raised $2.1 billion of a targeted $2.6 billion for its 14th fund, according to an SEC filing. The firm's prior fund, which closed in 2010, was for $2.5 billion. NEA invests in IT, energy …
Published on 5/10/2012
-
Prolor Biotech Inc. (NYSE-A:PBTH; Tel Aviv:PBTH) said late Thursday it is planning a follow-on underwritten by Jefferies; Ladenburg Thalmann; and Oppenheimer. Prolor was up $0.06 to $5.69 on Thursday. Prolor's lead …
Published on 5/10/2012
-
Dynavax Technologies Corp. (NASDAQ:DVAX) raised $74.4 million through the sale of 17.5 million shares at $4.25 in a follow-on underwritten by JPMorgan and Cowen. Dynavax proposed the offering late Tuesday when its stock…
Published on 5/9/2012
-
Rib-X Pharmaceuticals Inc. (New Haven, Conn.) postponed its planned IPO, citing market conditions. The move comes a day after the company's latest amendment to the offering. Rib-X hoped to sell 10 million shares at $6-$…
Published on 5/9/2012
-
Savient Pharmaceuticals Inc. (NASDAQ:SVNT) said on Wednesday it restructured debt and raised about $44 million through a sale of units comprising notes and warrants. The move comes after the Delaware Court of Chancery …
Published on 5/9/2012
-
Dendreon Corp. (NASDAQ:DNDN) fell $2.94 (25%) to $8.75 on Tuesday after it did not raise its sales outlook for Provenge sipuleucel-T despite reporting 1Q12 sales for the prostate cancer therapy that beat both the Street…
Published on 5/8/2012
-
Eleven Biotherapeutics Inc. (Cambridge, Mass.) raised $10 million in an extension of a series A round, bringing the total raised in the round to $45 million. New investor JAFCO joined existing investors Third Rock …
Published on 5/8/2012
-
Intercell AG (VSE:ICLL; OTCQX:INRLY) plans to raise EUR 25 million ($32.5 million) in a debt and equity financing from BB Biotech. The financing comprises EUR 20 million ($26 million) in a six-year secured loan that …
Published on 5/8/2012
-
Rib-X Pharmaceuticals Inc. (New Haven, Conn.) amended its IPO and now hopes to sell 10 million shares at $6-$7 per share. A $6.50 price would raise $65 million and value the company at $129.4 million. Deutsche Bank; …
Published on 5/8/2012
-
Sutro Biopharma Inc. (South San Francisco, Calif.) raised $16.5 million in the second tranche of a series C round, bringing the total raised in the round to $36.5 million. Skyline Ventures led the tranche, with …
Published on 5/8/2012
-
Cancer Genetics Inc. (Rutherford, N.J.) amended its IPO and now hopes to sell 4 million shares at $11-$13 per share. A $12 price would raise $48 million and value the cancer diagnostics company at $111.9 million. …
Published on 5/7/2012
-
Life sciences debt provider Oxford Finance LLC raised $271.4 million by packaging 51 of its loans into bonds sold to third party investors. The bonds pay 3.9% annual interest and have a class A2 rating from Moody's …
Published on 5/7/2012
-
Cancer immunotherapy company iTeos Therapeutics S.A. (Gosselies, Belgium) debuted on Thursday with a EUR 3 million ($4 million) series A round from Ludwig Institute for Cancer Research (LICR); Hunza Ventures; Life …
Published on 5/3/2012
-
Sequencing company Oxford Nanopore Technologies Ltd. (Oxford, U.K.) raised L31.4 million ($51.1 million) in a private placement to existing investors. Earlier this year, the company unveiled its nanopore single-strand …
Published on 5/3/2012